Chronic Migraine Epidemiology and Outcomes Study
NCT01648530 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16789
Last updated 2015-01-29
Summary
This is a population internet-based study to characterize migraine clinical course and impact on family.
Conditions
- Migraine Disorders
Interventions
- OTHER
-
No Treatment
No Treatment
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Medical Director · Allergan
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2013-11-30
- Completion
- 2013-11-30
More Related Trials
-
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
NCT01016834 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey
NCT06680206 ·Status: COMPLETED
-
Inflammatory Markers in Patients With Active Migraine Headaches
NCT00471861 ·Status: COMPLETED
-
Efficacy of Erenumab on Functional Impact of Migraine
NCT04465357 ·Status: COMPLETED ·Phase: PHASE4
-
Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine
NCT02037425 ·Status: COMPLETED ·Phase: PHASE4
-
Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura
NCT00126035 ·Status: COMPLETED ·Phase: NA
-
Aspirin Resistance in Women With Migraine
NCT01257893 ·Status: WITHDRAWN ·Phase: NA
-
Drug Use Investigation for IMIGRAN Tablet
NCT01376141 ·Status: COMPLETED
-
Consistency of Response With Rimegepant in Acute Treatment of Migraine
NCT06898047 ·Status: ACTIVE_NOT_RECRUITING
-
A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines
NCT01749410 ·Status: COMPLETED
-
Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex
NCT01450995 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study Of Migraine Evolution
NCT00460005 ·Status: COMPLETED
-
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
NCT01749423 ·Status: WITHDRAWN
-
Standardized sTudy With Almotriptan in eaRly Treatment of Migraine
NCT00725140 ·Status: COMPLETED
-
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
NCT05853900 ·Status: COMPLETED ·Phase: NA
-
AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance
NCT06507150 ·Status: RECRUITING ·Phase: NA
-
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
NCT01516892 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Effectiveness of a Headache Management Program in Primary Care Settings
NCT05067725 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine
NCT02828020 ·Status: COMPLETED ·Phase: PHASE3
-
Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine
NCT06412965 ·Status: COMPLETED
-
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
NCT02174861 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study
NCT04299958 ·Status: COMPLETED
-
Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®
NCT02502123 ·Status: COMPLETED
-
Inflammatory Markers Identification in Migraine Patients
NCT01618201 ·Status: UNKNOWN
-
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007)
NCT01657370 ·Status: COMPLETED ·Phase: PHASE2